PiRNA Obtained through Liquid Biopsy as a Possible Cancer Biomarker
- PMID: 37296747
- PMCID: PMC10252662
- DOI: 10.3390/diagnostics13111895
PiRNA Obtained through Liquid Biopsy as a Possible Cancer Biomarker
Abstract
In recent years PIWI-interacting RNAs (piRNAs) have gained the interest of scientists, mainly because of their possible implications in cancer. Many kinds of research showed how their expression can be linked to malignant diseases. However, most of them evaluated the expression of piRNAs in tumor tissues. It was shown how these non-coding RNAs can interfere with many signaling pathways involved in the regulation of proliferation or apoptosis. A comparison of piRNA expression in tumor tissue and adjacent healthy tissues has demonstrated they can be used as biomarkers. However, this way of obtaining samples has a significant drawback, which is the invasiveness of such a procedure. Liquid biopsy is an alternative for acquiring biological material with little to no harm to a patient. Several different piRNAs in various types of cancer were shown to be expressed in bodily fluids such as blood or urine. Furthermore, their expression significantly differed between cancer patients and healthy individuals. Hence, this review aimed to assess the possible use of liquid biopsy for cancer diagnosis with piRNAs as biomarkers.
Keywords: cancer biomarker; liquid biopsy; piRNAs; sncRNA.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Correlating tissue and plasma‑specific piRNA changes to predict their possible role in pancreatic malignancy and chronic inflammation.Biomed Rep. 2024 Oct 7;21(6):186. doi: 10.3892/br.2024.1874. eCollection 2024 Dec. Biomed Rep. 2024. PMID: 39420923 Free PMC article.
-
Piwi-interacting RNAs (piRNAs) and Colorectal Carcinoma: Emerging Non-invasive diagnostic Biomarkers with Potential Therapeutic Target Based Clinical Implications.Curr Mol Med. 2023;23(4):300-311. doi: 10.2174/1566524022666220124102616. Curr Mol Med. 2023. PMID: 35068393 Review.
-
PIWI/piRNA-mediated regulation of signaling pathways in cell apoptosis.Eur Rev Med Pharmacol Sci. 2022 Aug;26(16):5689-5697. doi: 10.26355/eurrev_202208_29503. Eur Rev Med Pharmacol Sci. 2022. PMID: 36066141 Review.
-
HPV status is associated with altered PIWI-interacting RNA expression pattern in head and neck cancer.Oral Oncol. 2016 Apr;55:43-48. doi: 10.1016/j.oraloncology.2016.01.012. Epub 2016 Feb 4. Oral Oncol. 2016. PMID: 26852287 Free PMC article.
-
Small non-coding RNA sequencing reveals global dysregulation of piwi-interacting RNA (piRNA) expression in gonadal malignant germ cell tumours.Andrology. 2023 May;11(4):738-755. doi: 10.1111/andr.13312. Epub 2022 Oct 26. Andrology. 2023. PMID: 36254403
Cited by
-
Non-Coding RNAs in Cancer: Structure, Function, and Clinical Application.Cancers (Basel). 2025 Feb 8;17(4):579. doi: 10.3390/cancers17040579. Cancers (Basel). 2025. PMID: 40002172 Free PMC article. Review.
-
Correlating tissue and plasma‑specific piRNA changes to predict their possible role in pancreatic malignancy and chronic inflammation.Biomed Rep. 2024 Oct 7;21(6):186. doi: 10.3892/br.2024.1874. eCollection 2024 Dec. Biomed Rep. 2024. PMID: 39420923 Free PMC article.
-
Characterization and comparative profiling of piRNAs in serum biopsies of pediatric Wilms tumor patients.Cancer Cell Int. 2025 Apr 26;25(1):163. doi: 10.1186/s12935-025-03780-4. Cancer Cell Int. 2025. PMID: 40287690 Free PMC article.
-
piR-38,736 promotes gastric cancer cell proliferation by downregulating SMAD4 expression.J Mol Histol. 2025 Apr 3;56(2):128. doi: 10.1007/s10735-025-10412-8. J Mol Histol. 2025. PMID: 40178733 Free PMC article.
-
A robust machine learning model based on ribosomal-subunit-derived piRNAs for diagnostic potential of nonsmall cell lung cancer across multicentre, large-scale of sequencing data.Clin Transl Med. 2025 Aug;15(8):e70418. doi: 10.1002/ctm2.70418. Clin Transl Med. 2025. PMID: 40714929 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources